549 related articles for article (PubMed ID: 32323067)
41. [Biologics for Chronic Rhinosinusitis].
Pinggera L; Innerhofer V; Fischer N; Riechelmann H
Laryngorhinootologie; 2020 Jul; 99(7):483-493. PubMed ID: 32585720
[TBL] [Abstract][Full Text] [Related]
42. [The perspectives of biologics in the treatment of chronic rhinosinusitis with nasal polyps].
Zhang L
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Nov; 37(11):853-855. PubMed ID: 37905479
[No Abstract] [Full Text] [Related]
43. A call for cost-effectiveness analysis for biologic therapies in chronic rhinosinusitis with nasal polyps.
Codispoti CD; Mahdavinia M
Ann Allergy Asthma Immunol; 2019 Sep; 123(3):232-239. PubMed ID: 31295554
[TBL] [Abstract][Full Text] [Related]
44. Mepolizumab in chronic rhinosinusitis with nasal polyposis.
Liu X; Charn TC; Wang DY
Immunotherapy; 2023 Oct; 15(14):1105-1116. PubMed ID: 37435679
[TBL] [Abstract][Full Text] [Related]
45. Biologics for chronic rhinosinusitis with nasal polyps: Economics and ethics.
Roland LT; Regenberg A; Luong AU; Wise SK; Toskala E; Lam KK; Levy JM; Franzese CB; Smith K; Kim J
Int Forum Allergy Rhinol; 2021 Nov; 11(11):1524-1528. PubMed ID: 34250730
[TBL] [Abstract][Full Text] [Related]
46. EUFOREA consensus on biologics for CRSwNP with or without asthma.
Fokkens WJ; Lund V; Bachert C; Mullol J; Bjermer L; Bousquet J; Canonica GW; Deneyer L; Desrosiers M; Diamant Z; Han J; Heffler E; Hopkins C; Jankowski R; Joos G; Knill A; Lee J; Lee SE; Mariën G; Pugin B; Senior B; Seys SF; Hellings PW
Allergy; 2019 Dec; 74(12):2312-2319. PubMed ID: 31090937
[TBL] [Abstract][Full Text] [Related]
47. The Role of Biologics in the Treatment of Chronic Rhinosinusitis.
Haloob N; Karamali K; Hopkins C
BioDrugs; 2023 Jul; 37(4):477-487. PubMed ID: 37318659
[TBL] [Abstract][Full Text] [Related]
48. Chronic rhinosinusitis with nasal polyps: insights into mechanisms of disease from emerging biological therapies.
Kariyawasam HH
Expert Rev Clin Immunol; 2019 Jan; 15(1):59-71. PubMed ID: 30370785
[No Abstract] [Full Text] [Related]
49. Adverse effects of dupilumab in chronic rhinosinusitis with nasal polyps. Case report and narrative review.
Nitro L; Bulfamante AM; Rosso C; Saibene AM; Arnone F; Felisati G; Pipolo C
Acta Otorhinolaryngol Ital; 2022 Jun; 42(3):199-204. PubMed ID: 35880360
[TBL] [Abstract][Full Text] [Related]
50. Therapeutic Antibodies for Nasal Polyposis Treatment: Where Are We Headed?
Agarwal A; Spath D; Sherris DA; Kita H; Ponikau JU
Clin Rev Allergy Immunol; 2020 Oct; 59(2):141-149. PubMed ID: 31073812
[TBL] [Abstract][Full Text] [Related]
51. Effect of monoclonal antibodies on olfactory dysfunction caused by chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis.
Tsetsos N; Markou K; Konstantinidis I
Int Forum Allergy Rhinol; 2020 Jul; 10(7):893-900. PubMed ID: 32250544
[TBL] [Abstract][Full Text] [Related]
52. Biologicals and Endoscopic Sinus Surgery for Severe Uncontrolled Chronic Rhinosinusitis With Nasal Polyps: An Economic Perspective.
van der Lans RJL; Hopkins C; Senior BA; Lund VJ; Reitsma S
J Allergy Clin Immunol Pract; 2022 Jun; 10(6):1454-1461. PubMed ID: 35231626
[TBL] [Abstract][Full Text] [Related]
53. Biologics for Nasal Polyps: Synthesizing Current Recommendations into a Practical Clinical Algorithm.
Godse NR; Keswani A; Lane AP; Lee SE; Sindwani R
Am J Rhinol Allergy; 2023 Mar; 37(2):207-213. PubMed ID: 36848277
[TBL] [Abstract][Full Text] [Related]
54. Economics of Medical and Surgical Management of Chronic Rhinosinusitis with Nasal Polyps: A Contemporary Review.
Chapurin N; Khan S; Gutierrez J; Soler ZM
Am J Rhinol Allergy; 2023 Mar; 37(2):227-231. PubMed ID: 36848274
[TBL] [Abstract][Full Text] [Related]
55. Very Rapid Improvement in Extended Nitric Oxide Parameters Is Associated With Clinical and Functional Improvement in Patients With Chronic Rhinosinusitis With Nasal Polyps Treated With Dupilumab.
Paoletti G; Casini M; Malvezzi L; Pirola F; Russo E; Nappi E; Muci GQ; Montagna C; Messina MR; Ferri S; Racca F; Lamacchia D; Cataldo G; Puggioni F; De Virgilio A; Ferreli F; Mercante G; Spriano G; Canonica GW; Heffler E
J Investig Allergol Clin Immunol; 2023 Dec; 33(6):457-463. PubMed ID: 38095494
[TBL] [Abstract][Full Text] [Related]
56. Chronic rhinosinusitis with nasal polyps: mechanistic insights from targeting IL-4 and IL-13 via IL-4Rα inhibition with dupilumab.
Kariyawasam HH
Expert Rev Clin Immunol; 2020 Dec; 16(12):1115-1125. PubMed ID: 33148074
[No Abstract] [Full Text] [Related]
57. Biomarkers guiding biological therapeutic strategies in chronic rhinosinusitis with nasal polyps: an emerging challenge.
Yan B; Zhang L
Expert Rev Clin Immunol; 2023; 19(8):827-830. PubMed ID: 37114372
[No Abstract] [Full Text] [Related]
58. EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023.
Fokkens WJ; Viskens AS; Backer V; Conti D; De Corso E; Gevaert P; Scadding GK; Wagemann M; Bernal-Sprekelsen M; Chaker A; Heffler E; Han JK; Van Staeyen E; Hopkins C; Mullol J; Peters A; Reitsma S; Senior BA; Hellings PW
Rhinology; 2023 Jun; 61(3):194-202. PubMed ID: 36999780
[TBL] [Abstract][Full Text] [Related]
59. Treatment options for chronic rhinosinusitis with nasal polyps.
Wallace DV
Allergy Asthma Proc; 2021 Nov; 42(6):450-460. PubMed ID: 34871152
[No Abstract] [Full Text] [Related]
60. Differential nasal swab cytology represents a valuable tool for therapy monitoring but not prediction of therapy response in chronic rhinosinusitis with nasal polyps treated with Dupilumab.
Danisman Z; Linxweiler M; Kühn JP; Linxweiler B; Solomayer EF; Wagner M; Wagenpfeil G; Schick B; Berndt S
Front Immunol; 2023; 14():1127576. PubMed ID: 37180133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
